North American Menopause Society

Short answer BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the hormones your body makes (estradiol, progesterone, testosterone, sometimes DHEA or thyroid hormones) to treat symptoms of low or changing hormones. You might consider it if you have menopause/perimenopause or low‑testosterone symptoms and a clinician confirms hormone deficiency and that the therapy is appropriate for you. What BHRT is, in more detail “Bioidentical” means the molecule matches human hormones (e.g., 17β‑estradiol, micronized progesterone). BHRT can be given as FDA‑approved products (patches, pills, gels) or as custom‑compounded formulations (creams, lozenges, pellets) made by specialty pharmacies. Delivery methods include patches, gels, creams, injections, and subcutaneous pellets. Each has different dosing characteristics and risks. Who might need BHRT Women with moderate–severe menopausal symptoms: hot flashes, night sweats, sleep disruption, troublesome mood swings, vaginal dryness and painful intercourse, or bothersome irregular bleeding where hormone therapy is appropriate. Men with clinically low testosterone and consistent symptoms: low libido, erectile difficulties, persistent fatigue, loss of muscle mass or unexplained mood changes — and confirmed low labs. People whose quality of life is substantially affected by hormone deficiency and who want treatment after discussing risks/benefits with a clinician. How to know if you need it — sensible steps See a clinician (primary care, gynecologist, urologist, or endocrinologist) experienced in hormone care or a menopause/andrology clinic. Give a clear symptom history and medical history (including breast cancer, clotting disorders, stroke, liver disease, smoking, family history). Get appropriate lab tests (examples): serum estradiol, FSH/LH (for menopausal evaluation), total and free testosterone, SHBG, TSH, CBC, CMP, lipids and glucose/HbA1c as indicated. Timing matters (some hormones vary by cycle). Saliva testing is generally not a reliable diagnostic method for systemic hormone replacement. Discuss treatment options (FDA‑approved vs. compounded BHRT), risks, how you’ll be monitored, and alternatives (nonhormonal therapies, lifestyle, SSRIs/SNRIs for hot flashes, local vaginal estrogen for vaginal symptoms). If therapy starts, expect follow‑up labs and symptom reassessment (commonly after 3 months and then periodically). Benefits vs. risks — key points Benefits: symptom relief (hot flashes, vaginal dryness, libido, energy, bone protection in some situations). Risks: depend on the hormones and your health profile. Estrogen therapy increases certain risks in some people (e.g., blood clots, stroke) and is generally avoided or used cautiously in people with estrogen‑sensitive cancer or prior clotting events. Note that long‑term safety data for some compounded products (particularly pellets) are limited. The claim “BHRT is always safer because it’s natural” is not proven; use evidence and an individualized risk assessment. Types and controversies to be aware of Compounded pellets are popular but carry concerns (infection, extrusion, difficulty adjusting dose, variable compounding standards). The FDA has approved bioidentical hormone products (e.g., estradiol patches, micronized progesterone). Compounded products are not FDA‑approved and may have variable dosing/purity. The FDA and medical societies urge caution and informed consent. Specific brands and services (options to consider) Mayo Clinic Menopause Clinic (evidence‑based specialty care) — good if you want a center with a multi‑disciplinary, research‑based approach. North American Menopause Society (NAMS) — not a treatment provider but an excellent, evidence‑based resource for patients and clinicians about menopause and hormone therapy. BioTE Medical — a nationwide network that focuses on pellet BHRT; widely available if you specifically want pellet therapy, but understand pellets have pros/cons and are somewhat controversial. Defy Medical — a telemedicine clinic that offers hormone therapy for men and women, convenient for remote patients; check reviews, credentials, and whether follow‑up labs are included. When considering any provider: verify clinician credentials, ask how they monitor therapy, whether they use FDA‑approved formulations first, and which compounding pharmacy they use (ask for pharmacy accreditation). Questions to ask a provider Do you prefer FDA‑approved or compounded bioidentical hormones for my situation, and why? Which tests will you run before starting therapy and for follow‑up? How often will we monitor? What are the specific benefits and risks for someone with my health profile? What delivery method do you recommend (patch/gel/pill/pellet) and why? What happens if I want to stop or change dose? Which compounding pharmacy do you use and is it accredited? When to get urgent care or avoid BHRT Don’t start BHRT if you are pregnant, breastfeeding, or have active hormone‑sensitive cancer without oncology input. Immediate evaluation is needed for new/unexplained chest pain, sudden shortness of breath, or sudden limb swelling if you’re on estrogen therapy — these can be signs of a blood clot. Bottom line BHRT can help many people with hormone‑related symptoms, but it’s not automatically the right or safest choice for everyone. The right next step is a medical evaluation that includes symptom assessment and labs, a discussion of risks versus benefits, and a treatment plan with appropriate monitoring. If you want, tell me your main symptoms and age and I can suggest which specialist to see and which labs are most relevant.

Mentioned in position 2 of 4

Good question — there’s a big difference between thoughtful, evidence‑based BHRT care and “hormone mills” that push one‑size‑fits‑all treatments, unvalidated testing, or aggressive marketing. Below is a practical approach you can use to vet clinics, plus specific organizations/services to consider. What to require from a legitimate BHRT clinic Board‑certified clinician with hormone expertise: look for a board‑certified endocrinologist, gynecologist, or family medicine/menopause practitioner — ideally with a menopause credential (NAMS Certified Menopause Practitioner/NCMP) or significant endocrinology experience. Evidence‑based assessment: baseline history + appropriate serum labs (not just saliva tests) and relevant imaging/screening (mammogram, DEXA when indicated). Individualized plans that prefer FDA‑approved hormones when appropriate and explain risks/benefits. Compounded meds only when necessary and from accredited pharmacies. Clear informed consent, realistic expectations, and a plan for monitoring and follow‑up (labs and symptom checks). Transparent pricing and no pressure sales, especially no pressure to buy proprietary pellets, supplements, or lengthy “packages.” Red flags (avoid these) Prescribing hormones on symptom checklist alone with no labs or physical exam. Heavy reliance on saliva or unvalidated home tests for dosing decisions. One‑dose‑fits‑all protocols, automatic pellet implantation without individualized discussion. (Pellet therapy providers often market aggressively.) No follow‑up or no monitoring labs (hematocrit, estradiol/testosterone, liver, lipids, PSA when applicable). Clinics that double as supplement retailers or push expensive “programs” more than medical care. Specific reputable organizations and services (and why) Mayo Clinic, Cleveland Clinic, Johns Hopkins Medicine, Massachusetts General Hospital / Brigham and Women’s (Harvard) — academic medical centers with multidisciplinary menopause/endocrine programs and evidence‑based care. Good for second opinions or if you want clinic-based care. North American Menopause Society (NAMS) — authoritative clinical guidance and directory for NCMP providers. Use their site to find credentialed menopause practitioners. The Endocrine Society — clinical practice guidelines and educational resources useful for evaluating whether a clinic follows current standards. LabCorp and Quest Diagnostics — widely used, reliable labs for serum hormone testing (estradiol, total testosterone, SHBG, FSH/LH, TSH, etc.). Prefer serum testing through reputable labs over saliva tests. Compounding pharmacies: look for PCAB accreditation or USP <795>/<797> compliance. (Examples often used by clinics include Wedgewood Pharmacy and ImprimisRx — verify current accreditation before ordering.) Always ask the clinic which pharmacy they use and check that pharmacy’s accreditation status. Cautionary example: BioTE (a large pellet-therapy brand) — many clinics use BioTE pellets. Pellet therapy has known pros and cons and is promoted aggressively; treat as a red flag if it’s pushed as the default without discussion of alternatives. Questions to ask when you call or visit Are you board‑certified? What specialty and do you have NAMS/menopause training? What baseline tests will you do before starting hormones? (Expect serum estradiol/testosterone as applicable, CBC/hematocrit, LFTs, lipids, TSH, and screening like mammogram/DXA as indicated.) Do you use saliva or dried‑blood‑spot testing to dose hormones? (If yes: ask why — that is not standard.) Do you use FDA‑approved hormone formulations before compounding? If compounding, which pharmacy and is it PCAB‑accredited? How often will you follow up and repeat labs? What monitoring will you do for safety (e.g., hematocrit for testosterone, PSA for men, estradiol levels, etc.)? What are the risks and benefits, and what are alternatives? What outcomes do I realistically expect? Monitoring basics (typical, non‑prescriptive) Women on estrogen/progesterone: baseline mammogram screening per guidelines, periodic symptom review, and serum testing as indicated. Men on testosterone: baseline total testosterone, hematocrit, PSA, lipids; repeat testosterone and hematocrit about 3 months after starting/change, then every 6–12 months. Always ensure labs and clinical follow‑up are part of the program. How to verify credentials and reputation Verify board certification on ABMS Certify (certificationmatters.org) or state medical board. Check for NAMS NCMP listing if menopause care is the focus. Read patient reviews but weigh clinical transparency and credentials more heavily than marketing. If something feels rushed, salesy, or secretive, get a second opinion — an academic center is a good place to do that. If you want next steps If you prefer clinic care: consider scheduling with an academic center (Mayo, Cleveland Clinic, Johns Hopkins, Mass General) or a local NAMS‑listed practitioner. If you prefer a private clinic, ask the specific questions above and insist on serum labs and a monitoring plan. If you want, tell me your city or ZIP and I can suggest local clinics or academic centers to consider. I can also draft a one‑page checklist you can take to an appointment if that would help.

Mentioned in position 1 of 7

Short answer BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the hormones your body makes (estradiol, progesterone, testosterone) to treat symptoms of hormone deficiency (most commonly menopausal or low‑testosterone symptoms). Whether you “need” it depends on your symptoms, medical history and risk factors. See a clinician to review symptoms, run appropriate tests, and discuss risks and alternatives. What BHRT is (brief) “Bioidentical” means the molecular structure matches human hormones (e.g., 17β‑estradiol, micronized progesterone). BHRT can be delivered as FDA‑approved products (transdermal estradiol patches, oral micronized progesterone) or as compounded formulations made by pharmacies to individualized doses and combinations. Forms: pills, patches, topical gels/creams, vaginal rings/creams, injections, and subcutaneous pellets. How BHRT differs from conventional HRT Many conventional prescription products (for example, estradiol patches or micronized progesterone) are already bioidentical. The main difference people cite is compounded BHRT, which is customized but is not FDA‑tested for safety/consistency. Transdermal estradiol (patch/gel) avoids first‑pass liver metabolism and is generally associated with lower risk of certain clotting problems compared with oral estrogen. Who might be a candidate Typical candidates: Women with bothersome menopausal symptoms (hot flashes, night sweats, sleep disturbance, severe mood changes, vaginal dryness, painful intercourse) that affect quality of life. Women with premature ovarian insufficiency or surgical menopause. Men with clinically low testosterone documented by symptoms + laboratory evidence. Factors that influence the decision: age, time since menopause, personal/family history of breast cancer, blood clots, stroke, heart disease, liver disease, and smoking. What tests and evaluation are commonly used Thorough history and physical exam (menstrual status, symptom pattern, medication use, family history). Common labs (individualized): Women: FSH, estradiol (note: single estradiol levels can be misleading in perimenopause), TSH, CBC, lipids, fasting glucose. Baseline mammogram and pelvic exam as appropriate. Men: two morning total testosterone measurements on separate days (plus free testosterone if needed), SHBG, CBC, PSA (age‑appropriate), lipids, glucose. Beware of saliva tests: they are popular in some clinics but are not well validated for guiding therapy in most settings. Benefits and risks Benefits: best therapy for vasomotor symptoms and often improves sleep, mood, sexual function (with appropriate hormones). Risks: depends on hormone type/dose/route and your health. Possible increased risk of blood clots, stroke, gallbladder disease, and, with some regimens and durations, possible increased breast cancer risk. Transdermal estradiol and micronized progesterone are thought to have a safer profile for clot risk than oral estrogen and some synthetic progestins, but individual risk varies. Compounded BHRT lacks the same regulatory oversight—potency and purity can vary. Practical steps to take If you have bothersome symptoms, book an appointment with a clinician who manages hormones (menopause specialist, OB/GYN, endocrinologist, or experienced primary care doctor). Bring a symptom list and relevant family history (breast cancer, clotting disorders, heart disease). Get recommended baseline tests and discuss treatment options (nonhormonal and hormonal). If you start therapy, expect follow‑up to reassess symptoms and monitor safety. Specific product examples (FDA‑approved options I can mention) Estradiol patches/gels (transdermal): Vivelle‑Dot, Climara — good for systemic estrogen with lower first‑pass liver effects. Oral estradiol: Estrace — commonly used when oral route preferred. Micronized progesterone: Prometrium — a bioidentical progesterone available as an FDA product; used to protect the uterus when systemic estrogen is given to women with a uterus. Testosterone (men; and sometimes off‑label for women under specialist care): AndroGel, Testim, Aveed, Natesto — require careful monitoring. Vaginal/local products for GSM (genitourinary syndrome of menopause): local low‑dose estradiol rings/creams (Estring, vaginal estradiol creams) for vaginal dryness and painful intercourse. DHEA for vaginal symptoms (prescription prasterone/Intrarosa in some countries) may be an option for certain women. When to avoid BHRT (general cautions) Active or recent breast cancer (discuss with oncologist), known estrogen‑sensitive cancers, active liver disease, known history of venous thromboembolism or high clot risk, uncontrolled cardiovascular disease—these may preclude hormone therapy or require specialist input. Alternatives Lifestyle measures (cooling techniques, weight loss, exercise), nonhormonal medications for hot flashes (SSRIs/SNRIs such as venlafaxine, other options like gabapentin, clonidine), vaginal moisturizers and lubricants for dryness, psychologic therapies for mood/sleep. Resources and guidelines North American Menopause Society (NAMS) and the Endocrine Society provide evidence‑based guidance on hormone therapy and BHRT. Your clinician can help interpret guidelines for your situation. Bottom line BHRT can be very effective for hormone‑related symptoms, but it isn’t right for everyone. If you think you might benefit, make an appointment with a provider experienced in menopause or hormone therapy, get recommended tests, and have a shared decision‑making discussion about expected benefits, risks, and monitoring. If you want, tell me your age, sex, and main symptoms and I can suggest what to ask your clinician and which tests are most relevant.

Mentioned in position 11 of 12

Short answer: usually yes — it’s often not “too late” to start HRT in your late 50s, but whether it’s a good idea depends on which kind of HRT you mean, your health history, and your priorities. I’ll summarize both common meanings (menopause HRT and gender‑affirming HRT), what to expect, risks, and practical next steps. Which HRT do you mean? Menopausal HRT (estrogen ± progestogen) for hot flashes, night sweats, vaginal dryness, bone protection, etc.? Gender‑affirming HRT (feminizing or masculinizing) for a transgender/non‑binary transition? If you tell me which you mean I can tailor the advice. Below is a clear overview for both. 1) Menopausal HRT (for hot flashes, vaginal symptoms, bone health) The usual guidance: starting HRT within about 10 years of menopause or under about age 60 tends to have the most favorable balance of benefits vs risks (“timing hypothesis”). Someone in their late 50s often still falls in that window, so many clinicians will consider it. Benefits: very effective for hot flashes/night sweats and for genitourinary syndrome of menopause (GSM). It can also help prevent bone loss. Risks and cautions: risks rise with age and depend on personal history — previous breast cancer, active or recent stroke, uncontrolled coronary disease, active venous thromboembolism (clotting), or severe liver disease are important contraindications. Combined estrogen + progestogen therapy modestly increases breast cancer risk with long use. There’s also a small increase in VTE and stroke risk (higher with oral estrogen than transdermal). Practical options and preferences: for older people or anyone with higher clot/CV risk, transdermal estradiol (patch or gel) is often preferred because it has lower VTE risk than oral estrogen. If you still have a uterus you typically need a progestogen along with systemic estrogen to protect the lining of the uterus; if you’ve had a hysterectomy you don’t. Specific product examples (discuss with your prescriber): Transdermal estradiol patches: Vivelle‑Dot, Climara (preferred for lower VTE risk). Estradiol gel: EstroGel, Divigel (transdermal alternative). Vaginal estrogen (for local GSM only): Estrace cream, Estring ring, Vagifem tablets (very low systemic exposure — safe for many people who can’t take systemic estrogen). Progestogens: micronized progesterone (Prometrium) is often recommended because it may have a friendlier side‑effect profile than some synthetic progestins; medroxyprogesterone acetate (Provera) is another commonly used option. Nonhormonal options: if hormones aren’t appropriate or preferred, options for hot flashes include SSRIs/SNRIs (paroxetine/Brisdelle is an FDA‑approved low‑dose option for hot flashes), venlafaxine, gabapentin, clonidine; for vaginal dryness, lubricants and moisturizers. 2) Gender‑affirming HRT (starting feminizing or masculinizing HRT in your late 50s) It is frequently still possible and beneficial to start later in life. Many people starting in their 50s+ still gain meaningful physical and psychological benefits. Considerations and risks: older age increases baseline cardiovascular risk and risk of blood clots, so assessment of heart disease, clotting history, smoking, and other risk factors is important. Dosage and route are often adjusted (lower starting doses; transdermal estradiol is commonly chosen for those with elevated VTE/CV risk). Typical approaches: Feminizing (for transfeminine people): estradiol (transdermal patches such as Vivelle‑Dot or Climara or gels like EstroGel) plus an antiandrogen (spironolactone (Aldactone) is widely used in the U.S.; some clinicians use cyproterone acetate or GnRH agonists where available). Transdermal estrogen is preferred if there are cardiovascular or clotting risks. Masculinizing (for transmasculine people): testosterone formulations — intramuscular injections (Depo‑Testosterone/testosterone cypionate), gels (AndroGel, Testim, Fortesta) or patches — are used. Monitor for erythrocytosis, lipids, and liver function. Baseline testing and monitoring: blood pressure, fasting lipids and glucose/HbA1c, liver tests, CBC, baseline hormone levels as appropriate, and sometimes bone density (DEXA) if fracture risk is a concern. Ongoing monitoring every 3–6 months initially, then annually once stable. Where to get care: Planned Parenthood, specialized gender clinics, or telemedicine providers that focus on transgender care (examples: Folx Health, Plume, QCare/PlushCare depending on location) can provide informed, monitored care. Practical next steps (regardless of which HRT you mean) Book an appointment with a clinician experienced in the type of HRT you want — a menopause specialist or gynecologist for menopausal HRT; an endocrinologist, trans health clinic, or experienced primary care clinician for gender‑affirming HRT. If you need telehealth, consider Folx Health or Plume for trans care; for menopause care, look for menopause clinics or a local gynecologist who follows North American Menopause Society (NAMS) guidance. Bring a brief health history and list of meds. Expect baseline tests: blood pressure, BMI, fasting glucose/HbA1c, lipids, liver tests, and possibly CBC and DEXA depending on bone risk. Discuss goals (symptom control, bone protection, feminization/masculinization), personal and family cancer history, clotting history, smoking, and cardiovascular risk. If you have contraindications you’ll review alternatives. If you start HRT, the clinician will recommend a specific formulation and monitoring schedule (often start low, monitor symptoms and labs, then adjust). Quick resources North American Menopause Society (NAMS) — good, evidence‑based menopause guidance. Planned Parenthood — local clinics and telehealth for both menopausal and trans health in many areas. For trans care: Folx Health, Plume (telehealth clinics specializing in transgender care). Bottom line: Late 50s is frequently still an appropriate time to start HRT, but the decision depends on your health profile and goals. Talk with a clinician experienced in the type of HRT you want; if you’d like, tell me which HRT you mean and a bit about your medical history and symptoms and I can give more tailored next steps.

Mentioned in position 21 of 21

Short answer: You may be in perimenopause if you’re having changes in your menstrual cycle plus symptoms like hot flashes, sleep or mood changes, or vaginal dryness. Perimenopause is the transition before menopause (menopause = 12 consecutive months without a period). What to look for Menstrual changes: shorter or longer cycles, missed periods, heavier or lighter bleeding, more irregularity. Vasomotor symptoms: hot flashes and night sweats. Sleep problems and fatigue. Mood changes: irritability, anxiety, or low mood. Vaginal dryness, painful sex, urinary symptoms. Changes in libido, concentration, or memory. Symptoms usually start in your 40s but can begin earlier (smoking, certain chemo, or surgery can cause earlier changes). How it’s diagnosed There’s no single definitive blood test for perimenopause. Hormone levels (FSH, estradiol, AMH) fluctuate and one measurement may be misleading. Pregnancy should be ruled out if you could still conceive. Clinicians usually make a diagnosis based on your symptoms and menstrual pattern. Menopause is confirmed retrospectively after 12 months without a period. When to see a clinician now Symptoms are disruptive to work, sleep, relationships, or mood. You have very heavy bleeding (soaking through a pad/tampon in an hour), bleeding after sex, or bleeding that concerns you. You have pelvic pain, fever, or other worrying symptoms. You want help with symptom treatments (HRT, nonhormonal meds, vaginal therapy) or contraception if you’re still having periods. What a clinician may do Review your history and medications, do a pelvic exam if indicated, and order tests to rule out other causes of bleeding. Discuss treatment options: lifestyle measures, vaginal moisturizers/lubricants, local vaginal estrogen for dryness, systemic hormone therapy (HRT) for hot flashes and other symptoms, or nonhormonal meds (some antidepressants, gabapentin) when HRT isn’t suitable. Risks/benefits are individualized. Practical resources and services (recommended) North American Menopause Society (NAMS) — evidence-based patient info and a “find-a-provider” tool for menopause specialists. Mayo Clinic patient info — clear summaries of symptoms and management. Planned Parenthood — accessible local care for reproductive issues, pregnancy testing, and basic gynecologic evaluation. Maven Clinic (telehealth) — women’s health specialists by telemedicine for convenience and follow-up. Flo or Clue (apps) — helpful for tracking cycles and symptoms to share with your clinician. EverlyWell or LetsGetChecked (home hormone kits) — can track hormones at home but interpret results cautiously; they’re not definitive for perimenopause. Next steps you can take today Start tracking cycles and symptoms (date of bleeding, hot flashes, sleep, mood). Take a pregnancy test if applicable. Make an appointment with your primary care doctor or gynecologist; ask for evaluation if symptoms are bothersome or bleeding is unusual. If you want, I can help draft questions to ask your clinician or help find local or telehealth providers. If you’d like, tell me your age, main symptoms, and whether you’re still having periods and I can give more tailored guidance.

Mentioned in position 1 of 8

Short answer BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the ones your body makes (estradiol, progesterone, testosterone) to treat symptoms caused by low hormones — most commonly menopause/perimenopause in people assigned female at birth and low testosterone in people assigned male at birth. Whether you “need” it depends on your symptoms, medical history, lab results, and your risk tolerance after discussing benefits and risks with a clinician. What BHRT is (and what people mean by it) “Bioidentical” means the hormone molecule matches human hormones (for example, 17β‑estradiol and micronized progesterone). Several FDA‑approved products use bioidentical hormones. BHRT can be given as pills, patches, gels, creams, rings, injections, or implanted pellets. There are two common uses: Menopause/perimenopause symptom relief (hot flashes, night sweats, vaginal dryness, mood/sleep problems). Treatment of clinically proven low testosterone in men (low energy, low libido, low muscle mass) or selected women in specialist care. Important distinction: FDA‑approved bioidentical hormone products (with consistent dosing and tested safety/efficacy) versus compounded BHRT (custom formulations from compounding pharmacies). Compounded products are not FDA‑approved and have variable dosing and quality. Potential benefits Effective relief of hot flashes, night sweats, vaginal dryness, and improved sleep, mood and quality of life for many people in menopause. Testosterone therapy can improve libido, energy and muscle mass in men with confirmed low testosterone. Potential risks and caveats Hormone therapy has risks: increased risk of blood clots, stroke, and (depending on type/duration) possibly breast cancer and gallbladder disease. Risks vary by age, dose, route, and whether progesterone is used with estrogen in people with a uterus. Compounded BHRT lacks large long‑term safety data and quality control compared with FDA‑approved products. Some delivery methods (pellets) have limited long‑term safety data and may be harder to dose or remove quickly. How to know if you need BHRT — practical steps Assess symptoms: keep a brief log of symptoms (hot flashes, sleep loss, vaginal symptoms, libido, mood, energy). Severity and effect on quality of life matter. See a clinician: primary care, OB/GYN, endocrinologist or men’s health/urology if male. A menopause specialist is ideal for complicated cases. Get an appropriate workup: For people with menopausal symptoms: history, physical exam, and—if needed—labs such as FSH (to confirm menopause in younger people), estradiol sometimes, and baseline screening (mammogram as recommended by age, lipid and metabolic screens as appropriate). For suspected low testosterone in men: at least two morning total testosterone levels, plus free testosterone if needed, and evaluation of causes; baseline PSA and hematocrit before and during therapy. Avoid relying on commercial salivary or urine “hormone” panels for diagnosis — blood tests interpreted by a clinician are standard. Review contraindications: active or recent estrogen‑dependent breast cancer, active blood clots or high clotting risk, uncontrolled cardiovascular disease or stroke risk, and some liver diseases are important reasons to avoid or modify therapy. Discuss options: nonhormonal treatments (SSRIs/SNRIs, gabapentin, lifestyle measures, vaginal moisturizers/lubricants, ospemifene for vaginal symptoms) may be alternatives for some people. If you choose hormone therapy, prefer FDA‑approved bioidentical products when possible (known dosing, manufacturing standards) and use the lowest effective dose for the shortest necessary time with regular follow‑up. Brands and services (examples and why) Estradiol patches/gels: Vivelle‑DOT, Climara (patches), EstroGel/Divigel (gels). Why: FDA‑approved, consistent dosing and widely used for menopausal symptoms. Oral progesterone: Prometrium (micronized progesterone). Why: FDA‑approved bioidentical progesterone (used for uterine protection when estrogen is given to people with a uterus). Vaginal estrogen: Estring, Vagifem (rings/tablets) or estradiol creams. Why: localized relief for vaginal dryness with low systemic absorption. Testosterone (men): AndroGel, Testim, Depo‑Testosterone (injections), Aveed. Why: FDA‑approved options with established dosing and monitoring standards. If considering compounded BHRT: use a compounding pharmacy accredited by the Pharmacy Compounding Accreditation Board (PCAB) and only under a clinician who will monitor you closely. Reputable resources and clinics: The North American Menopause Society (NAMS) for guidelines; large centers like Mayo Clinic or Cleveland Clinic have menopause programs and evidence‑based counseling. When to see a specialist right away Severe symptoms that interfere with daily life. Young people with early menopause/POI (premenopausal people in their 40s or younger). Complex medical history (history of breast cancer, blood clots, stroke, or serious heart disease). Considering long‑term testosterone in women or specialized compounded regimens. Bottom line BHRT can be very effective for hormone‑deficiency symptoms, but it isn’t automatically the right choice for everyone. Start by documenting symptoms, get evaluated by a clinician, have appropriate blood tests, review risks and benefits, and prefer FDA‑approved formulations unless there’s a clear, monitored reason to use compounded BHRT. If you want, tell me your age, sex assigned at birth, main symptoms, and any major medical history (breast cancer, blood clots, heart disease) and I can suggest which tests to ask for and what type of specialist to see.

Mentioned in position 12 of 12